By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endotis Pharma 

102 Route de Noisy
Parc Biotech
Romainville    93230  France
Phone: 33-1-48-464391 Fax: 33-1-48-469829


Company News
Endotis Pharma Intiates Phase IIa Study of First-in-Class Neutralizable Anticoagulant in Open-Heart Surgery 6/22/2011 9:11:04 AM
Endotis Pharma Reports Successful Completion of the Neutralization Study of the Anticoagulant EP217609 by Avidin in Healthy Subjects 11/15/2010 1:20:51 PM
Endotis Pharma Presents Data on the Neutralizable Anticoagulant EP217609 and Its Specific Antidote Avidin in an Extracorporeal Circulation Model 9/13/2010 2:45:56 PM
Endotis Pharma Presents Phase I Clinical Trial Results For A First-In-Class Synthetic Parenteral Neutralizable Anticoagulant EP217609 At The 21st International Congress On Thrombosis 7/8/2010 11:57:42 AM
Endotis Pharma Presents Data On The Neutralizable Anticoagulant EP217609 In An Extracorporeal Circulation Model 6/4/2010 2:43:32 PM
Endotis Pharma Reports The Successful Completion Of Phase I Clinical Trials Of The Neutralizable Anticoagulant EP217609 And Its Antidote Avidin Under Development For Use In Heart Surgery 4/30/2010 1:45:23 PM
Endotis Pharma EP80061 Small-Glyco Drug To Be Presented At The American Association for Cancer Research Meeting In Washington DC, April 17th To 21st, 2010 4/16/2010 3:21:48 PM
Endotis Pharma Presents Phase I Clinical Trials Results for EP42675, a First-in-Class Synthetic Parenteral Anticoagulant 12/4/2009 10:18:50 AM
Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma 11/5/2009 10:10:00 AM
Endotis Pharma Reports Successful Completion of Phase I Program with EP42675, a First in Class Synthetic Parenteral Anticoagulant 5/19/2009 10:49:53 AM